Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin

Tropical Medicine and International Health

Volumn 13, Issue 4, 2008, Pages 556-565

  Edwards, Tansy ^a   Harding Esch, Emma M ^a   Hailu, Girum ^b   Andreason, Aura ^a   Mabey, David C ^a   Todd, Jim ^c   Cumberland, Phillippa ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Future International Consulting Agency   (Ethiopia)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Azithromycin; Chlamydia trachomatis; Ethiopia; Polymerase chain reaction; Risk factors; Trachoma

Indexed keywords

AZITHROMYCIN;

ANTIBIOTICS; BACTERIAL DISEASE; BACTERIUM; CHILD HEALTH; COMPARATIVE STUDY; DISEASE TREATMENT; HEALTH EDUCATION; POLYMERASE CHAIN REACTION; RISK FACTOR; RURAL AREA; SECRETION;

ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; COMMUNITY; DEMOGRAPHY; ENVIRONMENTAL SANITATION; ETHIOPIA; FEMALE; FOLLOW UP; HEALTH EDUCATION; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; PERSONAL HYGIENE; POLYMERASE CHAIN REACTION; RISK FACTOR; STATISTICAL ANALYSIS; TRACHOMA;

AFRICA; EAST AFRICA; ETHIOPIA; SUB-SAHARAN AFRICA;

CHLAMYDIA TRACHOMATIS;

EID: 42149089998     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2008.02034.x     Document Type: Article

References (25)

1. Baggaley RF, Solomon AW, Kuper H et al. (2006) Distance to water source and altitude in relation to active trachoma in Rombo District, Tanzania. Tropical Medicine and International Health 11, 220 227.
2. Bejiga A Alemayehu W (2001) Prevalence of trachoma and its determinants in Dalocha District, Central Ethiopia. Ophthalmic Epidemiology 8, 119 125.
3. Berhane Y, Worku A Bejiga A (2006) National Survey on Blindness, Low Vision and Trachoma in Ethiopia. Federal Ministry of Health, Ethiopia.
4. Broman AT, Shum K, Munoz B et al. (2006) Spatial clustering of ocular chlamydial infection over time following treatment, among households in a village in Tanzania. Investigative Ophthalmology & Visual Science 47, 99 104.
5. Burton MJ, Holland MJ, Makalo P et al. (2005) Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 365, 1321 1328.
6. Cumberland P, Hailu G Todd J (2005) Active trachoma in children aged three to nine years in rural communities in Ethiopia: prevalence, indicators and risk factors. Transactions of the Royal Society of Tropical Medicine and Hygiene 99, 120 127.
7. Edwards T, Cumberland P, Hailu G et al. (2006) Impact of health education on active trachoma in hyperendemic rural communities in Ethiopia. Ophthalmology 113, 548 555.
8. Emerson PM, Lindsay SW, Alexander N et al. (2004) Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet 363, 1093 1098.
9. Gower EW, Solomon AW, Burton MJ et al. (2006) Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment. Investigative Ophthalmology & Visual Science 47, 4767 4771.
10. Kuper H, Solomon AW, Buchan J et al. (2003) A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infectious Diseases 3, 372 381.
11. Lee S, Alemayehu W, Melese M et al. (2007) Chlamydia on children and flies after mass antibiotic treatment for trachoma. American Journal of Tropical Medicine and Hygiene 76, 129 131.
12. Leyland A Goldstein H (2001) Multilevel Modelling of Health Statistics, Chapter 3. John Wiley & Sons Ltd, England.
13. Lietman T, Porco T, Dawson C et al. (1999) Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nature Medicine 5, 572 576.
14. Melese M, Alemayehu W, Bayu S et al. (2003) Low vision and blindness in adults in Gurage Zone, central Ethiopia. British Journal of Ophthalmology 87, 677 680.
15. Melese M, Chidambaram JD, Alamayehu W et al. (2004) Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass treatment antibiotic treatments. Journal of the American Medical Association 292, 721 725.
16. Rabe-Hesketh S, Skrondal A Pickles A (2002) Reliable estimation of generalized linear mixed models using adaptive quadrature. The Stata Journal 2, 1 21.
17. Schemann JF, Sacko D, Malvy D et al. (2002) Risk factors for trachoma in Mali. International Journal of Epidemiology 31, 194 201.
18. Schemann JF, Guinot C, Ilboudo L et al. (2003) Trachoma, flies and environmental factors in Burkina Faso. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 63 68.
19. Solomon AW, Holland MJ, Burton MJ et al. (2003) Strategies for control of trachoma: observational study with quantitative PCR. Lancet 362, 198 204.
20. Thylefors B, Dawson CR, Jones BR et al. (1987) A simple system for the assessment of trachoma and its complications. Bulletin of the World Health Organisation 65, 477 483.
21. Treharne JD (1985) The community epidemiology of trachoma. Review of Infectious Diseases 7, 760 764.
22. West S, Munoz B, Bobo L et al. (1993) Nonocular Chlamydia infection and risk of ocular reinfection after mass treatment in a trachoma hyperendemic area. Investigative Ophthalmology and Visual Science 34, 3194 3198.
23. West SK, Munoz B, Lynch M et al. (1996) Risk factors for constant, severe trachoma among preschool children in Kongwa, Tanzania. American Journal of Epidemiology 143, 73 78.
24. West SK, Munoz B, Mkocha H et al. (2005) Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366, 1296 1300.
25. WHO (2003) Report on the 2nd Global Scientific Meeting on Trachoma. (WHO/PBD/GET 03.1) World Health Organisation, Geneva.